Material and methods

Reagents:
The standard phosphoramidites and ancillary reagents used on the oligonucleotide synthesis were obtained from Applied Biosystems and Link Technologies Ltd. 5'-Fluorescein CE phosphoramidite (FITC), Cyanine-3-CE phosphoramidite (Cyanine 540), 5'-Cholesterol-CE phosphoramidite and 5-FdU-CE phosphoramidite were acquired from Link Technologies. 5-Fluoro-2'-deoxyuridine (FdU) was purchased from Alfa Aesar. Centrifugation devices Nanosep 10K omega were purchased to Pall Life Science. Matrix for MALDI-TOF experiments was composed by 2',4',6'-trihydroxiacetophenone monohydrate (THAP, Aldrich) and ammonium citrate dibasic (Fluka) . Solvents for HPLC analysis were prepared using triethylammonium acetate (TEAA) and acetonitrile (Merck) as mobile phase. The rest of the chemicals are analytical reagent grade from commercial sources as specified. Circular genomic DNA from the virus M13mp18, 10, 50, and 1Kbp DNA Ladders were purchased from New England Biolabs and 100 bp DNA Ladders from Promega. Control drug, 5-Fluorouracil (5-FU) was purchased from Sigma. Ultrapure water (Millipore) was used in all experiments. HTB-38 was purchased from American Type Culture Collection, Manassas, VA and HCC2998 cell line was kindly provided by Dr. Diego Arango (Molecular Oncology Group; CIBBIM-Nanomedicine, Vall d'Hebron Institut of Research (VHIR)). Both cell lines were grown in DMEM supplemented with 10% fetal bovine serum (FBS), 50 i.u ml -1 penicillin and 50 µg ml -1 streptomycin. Cultures were grown at 37 °C in 5% CO2 humidified atmosphere. Cell membrane dyes WGA-488 and WGA-555 were kindly provided by the confocal microscopy service (ThermoFisher). Annexin V-FITC kit was obtained from ThermoFisher and used following manufacturer's instructions.
Instrumentation: Modified staple-strands for engineer the two DNA nanostructures were synthesized on an ABI 3400 DNA Synthesizer (Applied Biosystems). Analytic RP-HPLC was performed on a Waters chromatography system using XBridge TM OST C 18 (4.6 × 50 mm, 2.5 μm) column. The HPLC solvent used were; A, 5% ACN in 100 mM triethylammonium acetate (TEAA) (pH = 7) and solvent B, 70% ACN in 100 mM TEAA (pH = 7). Mass spectra were recorded on a MALDI Voyager DE RP time-of-flight (TOF) spectrometer (Applied Biosystems) equipped with nitrogen laser at 337 nm using a 3ns pulse. The matrix used contained 2,4,6-trihydroxyacetophenone (THAP, 10 mgmL -1 in ACN/ water 1:1) and ammonium citrate (50 Supporting Information mgmL -1 in water). Molecular absorption spectra between 220 and 550 nm were recorded with a Jasco V650 spectrophotometer. The temperature was controlled with an 89090A Agilent Peltier device. Hellma quartz cuvettes were used. The DNA nanostructures were annealed in an Eppendorf thermocycler (Boeker). Gels were imaged with a Gene Genius Bioimaging system (Syngene). AFM images were obtained by liquid tapping on a Nanoscope 3A Multimode 4 AFM, using Bruker SNL-10 ultra-sharp silicon tips. Imaging was then conducted using a TEM microscope, Jeol JEM 1010 100 kv with CCD Megaview 1kx1k (CCIT-University of Barcelona). The MTT and colony assays were measured in an automated spectrophotometric plate reader Glomax multi detection system (Promega). Internalization and apoptosis assays were measured with a Guava easyCyte™ flow cytometer (Millipore) and data was analysis with Guavasoft 3.1.1. The confocal images were acquired by using a TCS SP2 confocal microscope equipped with live cell chamber system (Leica).
Synthesis of modified oligonucleotides:
Standard staple-strand oligonucleotides were purchased to Sigma. Modified staple-strands were synthesized on ABI 3400 DNA Synthesizer, using the 200-nmol scale synthesis and the standard protocols. FITC, FdU, cholesterol and Cy3 phosphoramidites were site-specifically inserted into the standard sequence oligonucleotide.
FdU n oligonucleotides at the 3'-end were introduced using controlled pore glass functionalized with a 3'-succinyl-5-FdU solid support. To this end, the FdU was dimethoxytritilated and then was treated with anhydride succinic to obtain the corresponding succinate. Finally, the controlled pore glass solid support with 5-FdU was prepared following standard protocol. 1, 2 Modified oligonucleotides were deprotected with ammonia solution overnight at room temperature, followed by 1h at 55ºC. The FdU containing oligonucleotides were purified by OPC (oligonucleotide purified cartridge, Glen Research). The Cholesterol-staples were desalted by Sephadex G-25 with 30% acetonitrile (NAP-10, GE Healthcare). All the oligonucleotide staples were analyzed by RP-HPLC (Table S3 ) using two different HPLC gradients with a flow rate of 1 mlmin -1 . For the modified FdU staples the gradient used was: 0-50% acetonitrile in 20 min and for the modified staples with cholesterol, fluorescein and Cy3 moieties the gradient of acetonitrile was increased stepwise, starting with 0-15% in the initial 5 min, 15-40% over 1 min and 40-85% over the last 9 min. The length and homogeneity of the oligonucleotides were checked by MALDI-TOF (Table S3 ). The modified oligonucleotide concentration was Supporting Information 4 determined by absorbance measurements (260 nm) and their extinction coefficient calculated.
These samples were kept dry at -20 ºC until further use. All the modified oligonucleotides sequences are detailed in Table S1 . The standard strands for the DNA origami and DNA tetrahedron assemble are described below in Table S2 .
DNA nanostructures stability in cell medium. DNA tetrahedron (70 nmols) and DNA origami samples (10 nmols) were dissolved in cell medium (DMEM plus 10% Fetal bovine serum) and shacked at 37 °C for different periods of time (0, 15, 30, 60, 120, 240, 480 min and 24 h) . At the desired time the samples were removed from the shaker and frozen until further use. Then the samples were verified by gel electrophoresis. 2.5 % agarose in TAE/12.5 mM Mg buffer and run for 50 min at 100 V 1% agarose gels with the same buffer for the DNA origami. In the case of Td gels were run at 4 °C.
Supporting Information Table S1 . Modified staple-strands sequences for DNA tetrahedron and DNA origami. S3a GGTGATAAAACGTGTAGCAA
Chol-S3a
Chol-GGTGATAAAACGTGTAGCAA S3b GCTGTAATCGACGGGAAGAGCATGCCCATCCACTACTATGGCG
Chol-S3b
Chol-GCTGTAATCGACGGGAAGAGCATGCCCATCCACTACTAT
GGCG
S4a -CCTCGCATGACTCAACTGCC
Chol-S4a
Chol-CCTCGCATGACTCAACTGCC
S4b -TGGTGATACGAGGATGGGCATGCTCTTCCCGACGGTATTGGAC
Chol-S4b
Chol-TGGTGATACGAGGATGGGCATGCTCTTCCCGACGGTAT FdU n n in subscript stands for the number of FdU monomers, Chol for a cholesterol moiety and Cy3 for Cyanine 540. a The HPLC gradient was increased from 0-50% acetonitrile in 20 min; the remaining samples were analyzed following the HPLC gradient increased from; 0-15% over 5 min, followed by 15-40 % over 1 min and 40-85% over 9 min. 
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